Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

105

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions

Chronic Hepatitis B

Interventions

DRUG

LAM group

Subjects took one LAM 100mg tablet orally once daily and one ADV placebo tablet orally once daily.

DRUG

ADV group

Subjects took one ADV 10mg tablet orally once daily and one LAM placebo tablet orally once daily.